JPS6118778A - フローまたはピロロ‐ピリジン誘導体、その製法、およびそれらを含有する製剤 - Google Patents

フローまたはピロロ‐ピリジン誘導体、その製法、およびそれらを含有する製剤

Info

Publication number
JPS6118778A
JPS6118778A JP60141457A JP14145785A JPS6118778A JP S6118778 A JPS6118778 A JP S6118778A JP 60141457 A JP60141457 A JP 60141457A JP 14145785 A JP14145785 A JP 14145785A JP S6118778 A JPS6118778 A JP S6118778A
Authority
JP
Japan
Prior art keywords
formula
compound
mixture
group
tables
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP60141457A
Other languages
English (en)
Japanese (ja)
Inventor
アレキサンダー・ヴイツク
ジヨナサン・フロスト
パトリツク・ラルデノワ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo SA filed Critical Synthelabo SA
Publication of JPS6118778A publication Critical patent/JPS6118778A/ja
Pending legal-status Critical Current

Links

Classifications

    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F21—LIGHTING
    • F21V—FUNCTIONAL FEATURES OR DETAILS OF LIGHTING DEVICES OR SYSTEMS THEREOF; STRUCTURAL COMBINATIONS OF LIGHTING DEVICES WITH OTHER ARTICLES, NOT OTHERWISE PROVIDED FOR
    • F21V7/00—Reflectors for light sources
    • F21V7/04—Optical design
    • F21V7/08—Optical design with elliptical curvature
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/78—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP60141457A 1984-06-27 1985-06-26 フローまたはピロロ‐ピリジン誘導体、その製法、およびそれらを含有する製剤 Pending JPS6118778A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8410108A FR2566775B1 (fr) 1984-06-27 1984-06-27 Derives de tetrahydro-4,5,6,7 furo ou 1h-pyrrolo(2,3-c)pyridine, leur preparation et leur application en therapeutique
FR8410108 1984-06-27

Publications (1)

Publication Number Publication Date
JPS6118778A true JPS6118778A (ja) 1986-01-27

Family

ID=9305484

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60141457A Pending JPS6118778A (ja) 1984-06-27 1985-06-26 フローまたはピロロ‐ピリジン誘導体、その製法、およびそれらを含有する製剤

Country Status (21)

Country Link
US (1) US4621087A (enExample)
EP (1) EP0170549B1 (enExample)
JP (1) JPS6118778A (enExample)
KR (1) KR860000283A (enExample)
AR (1) AR240820A1 (enExample)
AT (1) ATE40367T1 (enExample)
AU (1) AU573856B2 (enExample)
CA (1) CA1273340A (enExample)
DE (1) DE3567869D1 (enExample)
DK (1) DK158952C (enExample)
ES (1) ES8604583A1 (enExample)
FI (1) FI82052C (enExample)
FR (1) FR2566775B1 (enExample)
GR (1) GR851567B (enExample)
HU (1) HU192236B (enExample)
IL (1) IL75632A0 (enExample)
MX (1) MX156795A (enExample)
NO (1) NO161742C (enExample)
NZ (1) NZ212556A (enExample)
PT (1) PT80718B (enExample)
ZA (1) ZA854827B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2635977B1 (fr) * 1988-09-07 1992-05-15 Synthelabo Utilisation de derives de tetrahydro-4,5,6,7 furopyridines pour obtenir des medicaments destines au traitement de l'obesite
CA1337695C (en) * 1988-09-23 1995-12-05 Jacques Gosteli Process for the production of 4,5,6,7-tetrahydrothieno-¬3,2-c|-pyridines
EP1147113B1 (en) 1999-01-19 2006-06-07 Neurosearch A/S Fused heterocyclic compounds and their use in the treatment of neurodegenerative diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2215948B1 (enExample) * 1973-02-01 1976-05-14 Centre Etd Ind Pharma
US4075215A (en) * 1973-02-01 1978-02-21 Centre D'etudes Pour L'industrie Pharmaceutique Thieno-pyridine derivatives
GB1484140A (en) * 1974-04-24 1977-08-24 Wyeth John & Brother Ltd Pyrrolopyridine derivatives
US4520025A (en) * 1982-07-21 1985-05-28 William H. Rorer, Inc. Bicyclic nitrogen heterocyclic ethers and thioethers, and their pharmaceutical uses
IL71661A0 (en) * 1983-04-27 1984-07-31 Boehringer Ingelheim Kg 4-phenyl-tetrahydro-furano-pyridines,their preparation and pharmaceutical compositions containing them
FR2570701B1 (fr) * 1984-09-27 1987-05-22 Synthelabo Derives de furo(3,2-c)pyridines, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
GR851567B (enExample) 1985-11-25
FI82052C (fi) 1991-01-10
FI852523A0 (fi) 1985-06-26
CA1273340A (en) 1990-08-28
HU192236B (en) 1987-05-28
ZA854827B (en) 1986-02-26
IL75632A0 (en) 1985-10-31
FR2566775B1 (fr) 1986-10-31
FI852523L (fi) 1985-12-28
AU573856B2 (en) 1988-06-23
US4621087A (en) 1986-11-04
MX156795A (es) 1988-10-04
DK158952C (da) 1991-01-21
PT80718B (fr) 1987-04-23
EP0170549B1 (fr) 1989-01-25
AR240820A1 (es) 1991-02-28
NO161742C (no) 1989-09-20
FR2566775A1 (fr) 1986-01-03
AR240820A2 (es) 1991-02-28
KR860000283A (ko) 1986-01-27
ATE40367T1 (de) 1989-02-15
ES544564A0 (es) 1986-02-01
EP0170549A1 (fr) 1986-02-05
AU4417785A (en) 1986-01-02
FI82052B (fi) 1990-09-28
NO852563L (no) 1985-12-30
ES8604583A1 (es) 1986-02-01
DE3567869D1 (en) 1989-03-02
PT80718A (fr) 1985-07-01
DK288685D0 (da) 1985-06-26
DK288685A (da) 1985-12-28
NZ212556A (en) 1987-10-30
HUT38345A (en) 1986-05-28
DK158952B (da) 1990-08-06
NO161742B (no) 1989-06-12

Similar Documents

Publication Publication Date Title
EP0944631B1 (de) Neue substituierte pyrazolderivate zur behandlung von herzkreislauferkrankungen
DE69006799T2 (de) Spirocyclische antipsychotische Mittel.
EP0110372B1 (de) 1-Phenylisochinolinderivate und Verfahren zu ihrer Herstellung, diese Verbindung enthaltende pharmazeutische Präparate und deren Anwendung
DE68927875T2 (de) N-substituierte azaheterocyclische Carbonsäuren
CH667090A5 (de) 1-aryl-5h-2,3-benzodiazepin-derivate und ein verfahren zu ihrer herstellung.
DE60036924T2 (de) 5-ht1f agonisten
DD265627A5 (de) Verfahren zur herstellung von 1-(4-aminophenyl)-4-methyl-7,8-methylendioxy-3,4-dihydro-5h-2,3-benzodiazepin
DE69922594T2 (de) Indazol-Derivate als 5-HT1F agonists
DD149071A5 (de) Herstellung 2-substituierter trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1h-pyrido eckige klammer auf 4,3-b eckige klammer zu indole
DE3023626A1 (de) 1,9-dihydroxyoctahydrobenzo eckige klammer auf c eckige klammer zu chinoline und 1-hydroxyhexahydrobenzo eckige klammer auf c eckige klammer zu chinolin-9 (8h)- one als antiemetika
EP0888313A1 (de) 2,3-benzodiazepinderivate und deren verwendung als ampa-rezeptoren-hemmer
DE69817557T2 (de) Piperidine derivate als inhibitoren der neurotransmitter-wiederaufbaunahme
EP0044989B1 (de) Neue, in 5-Stellung substituierte 5,10-Dihydro-11H-dibenzo (b,e)(1,4)diazepin-11-one, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE69810560T2 (de) Indanol-Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DE69229607T2 (de) 1,4-Dihydropyridin-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende therapeutische Zusammensetzung
DE2919800A1 (de) 4-amino-2-piperidinochinazolin-derivate, verfahren zu ihrer herstellung und solche derivate enthaltende arzneimittel
US4661498A (en) Furo 3,2-c pyridine derivatives and their use in treating depression and cerebral ischemia
DE69806750T2 (de) Amidinderivate als inhibitoren von no-synthase
JPS6118778A (ja) フローまたはピロロ‐ピリジン誘導体、その製法、およびそれらを含有する製剤
EP0258617B1 (de) 3,3-Disubstituierte-piperidin-2,6-dion-Derivate
DE2159324C2 (de) Benzobicycloalkanamine,-aminoxide, Verfahren zu ihrer Herstellung und pharmazeutische Mittel, welche diese Verbindungen enthalten
EP0002672A2 (de) Substituierte Pyrrolidine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
JPH037280A (ja) 新規ベンゾチオピラニルアミン
DE2456246A1 (de) Neue benzothiophene und verfahren zu ihrer herstellung
DE60105219T2 (de) ZNS wirksame Cyclobuta-Indol-Carboxamide, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate